PROGNOSTIC VALUE OF ELEVATED LIPOPROTEIN (A) CONCENTRATION TO PREDICT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS

被引：0
|
作者：
Shishikura, Daisuke [1 ]
Harada-Shiba, Mariko [1 ]
Fujisaka, Tomohiro [1 ]
Morita, Hideaki [1 ]
Kanzaki, Yumiko [1 ]
Hoshiga, Masaaki [1 ]
机构：
[1] Osaka Med & Pharmaceut Univ, Cardiol, Takatsuki, Osaka, Japan
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SaaG054
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
    Ferrieres, Jean
    Farnier, Michel
    Bruckert, Eric
    Vimont, Alexandre
    Durlach, Vincent
    Ferrari, Emile
    Gallo, Antonio
    Boccara, Franck
    Ferrieres, Dorota
    Beliard, Sophie
    ATHEROSCLEROSIS PLUS, 2022, 50 : 17 - 24
  • [22] Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and coronary heart disease in patients with heterozygous familial hypercholesterolemia
    Perani, G
    Tinelli, C
    Scullino, T
    Sartori, M
    Minoretti, P
    Geroldi, D
    Emanuele, E
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 143 - 143
  • [23] SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia
    Paquette, Martine
    Bernard, Sophie
    Baass, Alexis
    CLINICAL BIOCHEMISTRY, 2019, 66 : 44 - 48
  • [24] LDL-apheresis in treatment of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein (a) levels
    Bambauer, R
    Schiel, R
    Latzo, R
    Klinkmann, J
    TRANSFUSION SCIENCE, 1995, 16 (04): : 375 - 381
  • [25] LIPOPROTEIN(A) IS SIGNIFICANTLY HIGHER AND ASSOCIATED WITH INCREASED PREVALENCE OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN MUTATION-NEGATIVE FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
    Cavicchioli, A.
    Lugari, S.
    Vita, P.
    Mondelli, A.
    Pellegrini, E.
    Carubbi, F.
    Nascimbeni, F.
    ATHEROSCLEROSIS, 2020, 315 : E142 - E143
  • [26] Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease
    Vikulova, Diana N.
    Trinder, Mark
    Mancini, G. B. John
    Pimstone, Simon N.
    Brunham, Liam R.
    CANADIAN JOURNAL OF CARDIOLOGY, 2021, 37 (11) : 1733 - 1742
  • [27] TREATMENT EFFECTS OF ALIROCUMAB AS AN ADD-ON TO MAXIMALLY TOLERATED DOSE OF STATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AND/OR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Weiss, Robert J.
    Baum, Seth
    Blom, Dirk
    Bergeron, Jean
    Langslet, Gisle
    Sanganalmath, Santosh
    Yang, Julia
    Mandel, Jonas
    Shah, Prediman
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 154 - 154
  • [28] Underdiagnosis and Undertreatment of Heterozygous Familial Hypercholesterolemia in Association With Cardiovascular Disease
    Sekiguchi, Haruki
    Abe, Takuro
    Imu, Jihaeng
    Takano, Mayu
    Kimura, Makiko
    Ishida, Issei
    Sakai, Akiko
    Sato, Kayoko
    Hagiwara, Nobuhisa
    CIRCULATION, 2017, 136
  • [29] OVERWEIGHT/OBESITY AND PREVALENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: AN ANALYSIS FROM HELLAS-FH REGISTRY
    Barkas, F.
    Rizos, C.
    Liamis, G.
    Skoumas, I.
    Garoufi, A.
    Rallidis, L.
    Kolovou, G.
    Tziomalos, K.
    Skalidis, E.
    Sfikas, G.
    Kotsis, V.
    Doumas, M.
    Anagnostis, P.
    Lambadiari, V.
    Anastasiou, G.
    Koutagiar, I.
    Attilakos, A.
    Kiouri, E.
    Kolovou, V.
    Koutsogianni, A. -D.
    Zacharis, E.
    Koumaras, C.
    Antza, C.
    Boutari, C.
    Liberopoulos, E.
    ATHEROSCLEROSIS, 2023, 379
  • [30] CARDIOVASCULAR DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA SUBJECTS ON STATIN TREATMENT
    Marco-Benedi, V.
    Perez-Calahorra, S.
    Plana, N.
    Pedro-Botet, J. C.
    Ascaso, J.
    Lahoz, C.
    Almagro, F.
    Ros, E.
    Brea, A.
    Suarez-Tembra, M.
    Sanchez-Hernandez, R. M.
    Vila Belmonte, A.
    Civeira, F.
    ATHEROSCLEROSIS, 2016, 252 : E44 - E44
12345